Welcome to CSNpharm! For Research Use Only!
Home +1-708-781-1677 sales@csnpharm.com    

ERK

ERK

Cat. No. Product Name CAS No. Information
CSN16763 XMD8-92 1234480-50-2 XMD8-92 is an inhibitor of ERK5BMK1 The Kd values for BMK1 DCAMKL2 PLK4 and TNK1 are 80 nM 190 nM 600 nM and 890 nM respectively
CSN17855 XMD17-109 1435488-37-1 XMD17-109 is a specific ERK-5 inhibitor with an EC50 42 M in HEK293 cells
CSN18540 VX-11e 896720-20-0 VX-11e is a potent, selective, and orally bioavailable inhibitor of ERK (Extracellular Signal-Regulated Kinase) and is antitumor agent.
CSN15784 Ulixertinib   869886-67-9 Ulixertinib is a potent and reversible ERK1ERK2 inhibitor with IC50 of 0.3 nM for ERK2.
CSN23392 Ulixertinib HCl   1956366-10-1 Ulixertinib HCl the salt of ulixertinib is a reversible inhibitor of ERK1ERK2 It can inhibit cell proliferation
CSN13154 Tauroursodeoxycholate Sodium   35807-85-3 Tauroursodeoxycholate sodium can suppress ERK via PKC-mediated MKP-1 induction thus inhibiting neointimal hyperplasia of smooth muscle cells
CSN13643 SCH772984   942183-80-4 SCH772984 is a specific inhibitor of ERK12 with IC50 of 4 nM and 1 nM respectively
CSN17141 Pluripotin 839707-37-8 Pluripotin is a dual inhibitor of extracellular signal-regulated kinase 1 ERK1 MAPK3 and RasGAP It maintains embryonic stem cell ESC self-renewal
CSN21082 MK-8353 1184173-73-6 MK-8353 also known as SCH900353 is a potent and orally active ERK12 inhibitor and anticancer drug candidate currently being developed by Schering-Plough MK-8353 exhibited comparable potency with SCH772984 across various preclinical cancer models
CSN20623 LY3214996 1951483-29-6 LY3214996 can inhibit ERK1 and ERK2 with IC50s of 5 nM
CSN22441 KO-947 1695533-89-1 KO-947 is a potent and selective inhibitor of ERK12 kinases with potential clinical utility in MAPK pathway dysregulated tumors
CSN16271 GDC-0994   1453848-26-4 GDC-0994 is a selective inhibitor of ERK1/2 with IC50 value of 6.1 nM and 3.1 nM.
CSN19017 GDC-0994 HCl 2070009-58-2 GDC-0994 hydrochloride is highly selective for ERK1 and ERK2 with biochemical potency of 11 nM and 03 nM respectively
CSN13064 FR 180204 865362-74-9 FR 180204 is a potent and selective ATP-competitive inhibitor of ERK1 and ERK2 with Ki value of 031 M and 014 M respectively and has IC50 values of 051 and 033 M in enzymatic assays against ERK1 and ERK2 respectively
CSN17601 ERK5-IN-1 1234479-76-5 ERK5-IN-1 exhibits potent inhibition of ERK5 with cellular EC50 values of 019 M and enzymatic IC50 values of 0087 M and of LRRK2G2019S with enzymatic IC50 values of 0026M
CSN18045 DEL-22379 181223-80-3 DEL-22379 inhibits ERK dimerization with IC50 of 05 M
CSN13519 Corynoxeine 630-94-4 Corynoxeine is a potent ERK12 inhibitor of key PDGF-BB-induced VSMC proliferation and is a useful and prospective compound in the prevention and treatment for vascular diseases
CSN22365 CC-90003 1621999-82-3 CC-90003 is an irreversible inhibitor of ERK 12 with antitumor activity
CSN21094 AZD0364 2097416-76-5 AZD0364 is an ERK1 andor ERK2 kinase for the treatment of cancer
CSN19016 APS-2-79 2002381-25-9 APS-2-79 is an antagonist of MEK phosphorylation by RAF through direct binding of the KSR active site
CSN21221 AG-126   118409-62-4 AG 126 selectively inhibits the phosphorylation of ERK1 and ERK2 at 25-50 M.
CSN20372 ADA-07 N/A ADA-07 a T-LAK cell-originated protein kinase TOPK inhibitor is a promising chemopreventive or potential therapeutic agent against SUV-induced skin carcinogenesis that acts by specifically targeting TOPK
CSN22695 AX 15836 2035509-96-5
<< PREV 1 NEXT >>